Andrew Paul Mazar Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Andrew Paul Mazar is Chief Scientific Officer of Monopar Therapeutics. Currently has a direct ownership of 22,124 shares of MNPR, which is worth approximately $128,319. The most recent transaction as insider was on Mar 31, 2022, when has been sold 471 shares (Common Stock) at a price of $2.55 per share, resulting in proceeds of $1,201. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.1K
0% 3M change
0% 12M change
Total Value Held $128,319

Andrew Paul Mazar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
SELL
Payment of exercise price or tax liability
$1,201 $2.55 p/Share
471 Reduced 2.08%
22,124 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
-
1,606 Added 6.64%
22,595 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$2,154 $3.21 p/Share
671 Reduced 3.1%
20,989 Common Stock
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
1,937 Added 8.21%
21,660 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$1,785 $3.21 p/Share
556 Reduced 2.74%
19,723 Common Stock
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
1,606 Added 7.34%
20,279 Common Stock
Sep 30 2021
SELL
Payment of exercise price or tax liability
$2,294 $4.87 p/Share
471 Reduced 2.46%
18,673 Common Stock
Sep 30 2021
BUY
Exercise of conversion of derivative security
-
1,606 Added 7.74%
19,144 Common Stock
Jun 30 2021
SELL
Payment of exercise price or tax liability
$5,548 $5.89 p/Share
942 Reduced 5.1%
17,538 Common Stock
Jun 30 2021
BUY
Exercise of conversion of derivative security
-
3,212 Added 14.81%
18,480 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$4,107 $6.12 p/Share
671 Reduced 4.21%
15,268 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
1,937 Added 10.84%
15,939 Common Stock
APM

Andrew Paul Mazar

Chief Scientific Officer
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR